SofWave Medical Ltd. (TLV:SOFW)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,043.00
-75.00 (-2.41%)
Sep 17, 2026, 5:24 PM IDT
SofWave Medical Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,132 | 986 | 515 | 476 | 282 | 979 | |
Market Cap Growth | 19.06% | 91.50% | 8.08% | 68.92% | -71.19% | - |
Enterprise Value | 1,022 | 904 | 440 | 389 | 164 | 818 |
Last Close Price | 31.18 | 27.50 | 14.95 | 13.72 | 8.22 | 29.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 47.66 | 56.34 | - | - | - | - |
PS Ratio | 3.64 | 3.53 | 2.37 | 2.63 | 2.25 | 14.41 |
PB Ratio | 9.99 | 9.45 | 5.76 | 5.02 | 2.48 | 6.74 |
P/TBV Ratio | 9.99 | 9.45 | 5.76 | 5.02 | 2.48 | 6.74 |
P/FCF Ratio | 29.06 | 24.23 | - | - | - | - |
P/OCF Ratio | 27.42 | 23.25 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.29 | 3.24 | 2.03 | 2.15 | 1.31 | 12.04 |
EV/EBITDA Ratio | 28.11 | 35.85 | - | - | - | - |
EV/EBIT Ratio | 33.87 | 41.29 | - | - | - | - |
EV/FCF Ratio | 26.24 | 22.22 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.03 | 0.06 | 0.05 | 0.06 | 0.05 |
Debt / EBITDA Ratio | 0.12 | 0.13 | - | - | - | - |
Debt / FCF Ratio | 0.11 | 0.09 | - | - | - | - |
Net Debt / Equity Ratio | -0.97 | -1.03 | -0.82 | -0.88 | -0.93 | -0.94 |
Net Debt / EBITDA Ratio | -3.22 | -4.25 | 9.10 | 3.56 | 1.86 | 4.94 |
Net Debt / FCF Ratio | -2.82 | -2.63 | 7.57 | 3.44 | 2.70 | 8.40 |
Asset Turnover | 1.95 | 1.77 | 1.38 | 1.12 | 0.67 | 0.67 |
Inventory Turnover | 4.35 | 3.99 | 2.65 | 2.86 | 3.08 | 5.28 |
Quick Ratio | 2.19 | 1.97 | 1.81 | 2.05 | 2.98 | 4.50 |
Current Ratio | 2.46 | 2.30 | 2.22 | 2.42 | 3.38 | 4.80 |
Return on Equity (ROE) | 27.42% | 19.17% | -17.87% | -28.21% | -49.41% | -28.30% |
Return on Assets (ROA) | 11.83% | 8.69% | -5.17% | -11.14% | -20.28% | -17.16% |
Return on Invested Capital (ROIC) | 810.13% | 387.83% | -94.77% | -290.12% | -678.72% | -991.41% |
Return on Capital Employed (ROCE) | 26.00% | 20.50% | -14.00% | -29.50% | -51.50% | -18.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.33% | 1.77% | -3.22% | -6.26% | -24.36% | -2.17% |
FCF Yield | 3.44% | 4.13% | -1.89% | -5.08% | -13.90% | -1.66% |
Buyback Yield / Dilution | -15.79% | -15.83% | -0.53% | -0.26% | -44.98% | 45.50% |